We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUE
2926
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$271K ﹤0.01%
22,125
+1,354
+7% +$17.5K
NFO
2927
DELISTED
Invesco Insider Sentiment ETF
NFO
$271K ﹤0.01%
4,282
-472
-10% -$29.9K
FRO icon
2928
Frontline
FRO
$8.49B
$270K ﹤0.01%
60,950
-3,170
-5% -$14.2K
GNRC icon
2929
Generac Holdings
GNRC
$12.7B
$270K ﹤0.01%
5,884
-2,110
-26% -$100K
HEWJ icon
2930
iShares Currency Hedged MSCI Japan ETF
HEWJ
$752M
$270K ﹤0.01%
8,426
-138,927
-94% -$4.57M
QTWO icon
2931
Q2 Holdings
QTWO
$3.95B
$270K ﹤0.01%
+5,930
New +$256K
PRMW
2932
DELISTED
Primo Water Corporation
PRMW
$269K ﹤0.01%
18,273
-1,567
-8% -$24.9K
NDRO
2933
DELISTED
Enduro Royalty Trust
NDRO
$269K ﹤0.01%
75,812
CNTY icon
2934
Century Casinos
CNTY
$34.3M
$268K ﹤0.01%
35,900
OIA icon
2935
Invesco Municipal Income Opportunities Trust
OIA
$290M
$268K ﹤0.01%
36,200
+2,973
+9% +$22.9K
SKX
2936
DELISTED
Skechers
SKX
$268K ﹤0.01%
6,884
-39,824
-85% -$1.59M
NEWR
2937
DELISTED
New Relic, Inc.
NEWR
$268K ﹤0.01%
+3,618
New +$242K
FRBA icon
2938
First Bank
FRBA
$458M
$267K ﹤0.01%
18,540
RARE icon
2939
Ultragenyx Pharmaceutical
RARE
$2.66B
$267K ﹤0.01%
5,231
-1,140
-18% -$57.4K
FFIN icon
2940
First Financial Bankshares
FFIN
$4.99B
$266K ﹤0.01%
11,482
+2,194
+24% +$51.5K
AKP
2941
DELISTED
Alliance Californa Muni Fd
AKP
$266K ﹤0.01%
20,938
+3,618
+21% +$47.2K
SGYP
2942
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$266K ﹤0.01%
145,243
+17,000
+13% +$35.9K
EFC
2943
Ellington Financial
EFC
$1.74B
$265K ﹤0.01%
+17,883
New +$265K
NRO
2944
Neuberger Real Estate Securities Income Fund Inc
NRO
$187M
$265K ﹤0.01%
58,182
-91,959
-61% -$430K
ZNH
2945
DELISTED
China Southern Airlines Company Limited
ZNH
$265K ﹤0.01%
+5,029
New +$302K
DBX icon
2946
Dropbox
DBX
$7.41B
$264K ﹤0.01%
+8,450
New +$255K
NTLA icon
2947
Intellia Therapeutics
NTLA
$1.68B
$264K ﹤0.01%
+12,527
New +$308K
LUNA
2948
DELISTED
Luna Innovations Incorporated
LUNA
$264K ﹤0.01%
81,459
AKAM icon
2949
CALL
Akamai
AKAM
$16.8B
$263K ﹤0.01%
34,600
-1,600
-4% -$109K
BPT
2950
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$263K ﹤0.01%
+10,983
New +$241K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.